4-Pyrimidin-2-yl-piperazine-1-carboxylic acid pyrazol-1-yl ester | 548767-69-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 4-Pyrimidin-2-yl-piperazine-1-carboxylic acid pyrazol-1-yl ester
• 英文别名: Pyrazol-1-yl 4-pyrimidin-2-ylpiperazine-1-carboxylate
• CAS: 548767-69-7
• 化学式: C₁₂H₁₄N₆O₂
• 分子量: 274.282
• InChiKey: HVUKGYTUFPLRSM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  76.4
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  1-(2-嘧啶基)哌嗪 、 N-(3-氨基丙基)丙烷-1,3-二胺-2-(氯甲基)噁丙环(1:1) 生成 4-Pyrimidin-2-yl-piperazine-1-carboxylic acid pyrazol-1-yl ester
  参考文献：
  名称：

  Compounds and uses thereof for decreasing activity of hormone-sensitive lipase

  摘要：

  使用化合物抑制激素敏感性脂肪酶，包括这些化合物的药物组合物，使用这些化合物和组合物的治疗方法，以及新化合物。目前的化合物是激素敏感性脂肪酶的抑制剂，可能在治疗和/或预防需要降低激素敏感性脂肪酶活性的医学疾病中有用。

  公开号：

  US20030166644A1

文献信息

• Use of compounds for decreasing activity of hormone-sensitive
  申请人：——

  公开号：US20030166690A1

  公开（公告）日：2003-09-04

  Use of compounds to inhibit hormone-sensitive lipase, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and novel compounds. The present compounds are inhibitors of hormone-sensitive lipase and may be useful in the treatment and/or prevention of medical disorders where a decreased activity of hormone-sensitive lipase is desirable.

  使用化合物来抑制激素敏感性脂肪酶，包括这些化合物的制药组合物，使用这些化合物和组合物的治疗方法，以及新颖的化合物。这些化合物是激素敏感性脂肪酶的抑制剂，可用于治疗和/或预防需要降低激素敏感性脂肪酶活性的医学疾病。
• COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE
  申请人：NOVO NORDISK A/S

  公开号：EP1458374A2

  公开（公告）日：2004-09-22
• US7067517B2
  申请人：——

  公开号：US7067517B2

  公开（公告）日：2006-06-27
• US7279470B2
  申请人：——

  公开号：US7279470B2

  公开（公告）日：2007-10-09
• [EN] COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE<br/>[FR] COMPOSES RALENTISSANT L'ACTIVITE DE LA LIPASE HORMONO-SENSIBLE
  申请人：NOVO NORDISK AS

  公开号：WO2003051841A2

  公开（公告）日：2003-06-26

  Carbamates and related compounds of formula R1 R2NCO-Y or R1 R2NCS-Y wherein R1 and R2 are hydrogen, alkyl, aryl, heteroaryl or may together form a piperidine, piperazine, morpholine or other heterocyclic ring, are inhibitors of hormone sensitive lipase and are useful for the treatment of any disorder where it is desirable to modulate the plasma level of free fatty acids, glycerol, LDL-cholesterol, HDL-cholesterol, insulin and/or glucose; and or modulate intracellular triacylglycerol and cholesterol stores, intracellular level of fatty acids, fatty acid esters such as diacylglycerols, phosphatidic acids, long chain acyl-CoA's as well as citrate or malonyl-CoA; and or increase insulin sensitivity ; and or modulate insulin secretion from pancreatic beta cells. More particularly said disorders are selected from the group consisting of insulin resistance, diabetes type 1, diabetes type 2, metabolic syndrome X, impaired glucose tolerance, hyperclycemia, dislipidemia, obesity, abnormalities of lipoprotein metabolism and any combinations. thereof.